Parent Financial Statements (Tables)

9 Months Ended

Jun. 30, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Balance Sheets

Advanced BioEnergy, LLC (Unconsolidated)

Balance Sheets

(Dollars in thousands)

	June 30, 2016			September 30, 2015
	(Dollars in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	4,726		$	8,158
Restricted cash		1,533			1,500
Other receivable		—			6
Total current assets		6,259			9,664
Property and equipment, net		96			211
Other assets:
Investment in ABE Fairmont		—			108
Investment in ABE South Dakota		20,944			22,717
Other assets		32			32
Total assets	$	27,331		$	32,732
LIABILITIES AND MEMBERS’ EQUITY
Liabilities:
Accrued expenses	$	103		$	295
Other liabilities		—			21
Total liabilities		103			316
Members’ equity:
Members’ capital, no par value, 25,410,851 units issued and outstanding		48,638			48,638
Accumulated deficit		(21,410	)		(16,222	)
Total members’ equity		27,228			32,416
Total liabilities and members’ equity	$	27,331		$	32,732

Statements of Operations

Advanced BioEnergy, LLC (Unconsolidated)

Statements of Operations

(Dollars in thousands)

(Unaudited)

	Three Months Ended						Nine Months Ended
	June 30, 2016			June 30, 2015			June 30, 2016			June 30, 2015
	(Dollars in thousands)						(Dollars in thousands)
Equity in earnings (losses) of consolidated subsidiary	$	(420	)	$	707		$	(4,773	)	$	740
Selling, general and administrative expenses		(162	)		(113	)		(455	)		(447	)
Operating income (loss)		(582	)		594			(5,228	)		293
Other expense		—			—			(6	)		—
Interest income		5			6			46			16
Net income (loss)		(577	)		600			(5,188	)		309

Statements of Cash Flows

Advanced BioEnergy, LLC (Unconsolidated)

Statements of Cash Flows

(Dollars in thousands)

(Unaudited)

	Nine Months Ended
	June 30, 2016			June 30, 2015
	(Dollars in thousands)
Cash flows from operating activities:
Net income (loss)	$	(5,188	)	$	309
Adjustments to reconcile net income (loss) to operating activities cash flows:
Depreciation		83			99
Equity in earnings of consolidated subsidiaries		4,773			(740	)
Gain on disposal of fixed assets		7			—
Amortization of deferred revenue and rent		(21	)		(21	)
Change in working capital components:
Other receivable		6			(11	)
Prepaid expenses		—			(4	)
Accrued expenses		(192	)		(59	)
Net cash (used in) operating activities		(532	)		(427	)
Cash flows from investing activities:
Proceeds from sale of assets		25			—
Change in restricted cash		(33	)		—
Net cash (used in) investing activities		(8	)		—
Cash flows from financing activities:
Distribution to subsidiary		(3,000	)		—
Distribution from subsidiary		108			—
Net cash (used in) financing activities		(2,892	)		—
Net (decrease) in cash and cash equivalents		(3,432	)		(427	)
Beginning cash and cash equivalents		8,158			8,988
Ending cash and cash equivalents	$	4,726		$	8,561